Over 500 Total Lots Up For Auction at One Location - NJ 06/15

Artificial intelligence in healthcare market forecast to reach more than $7 billion by 2022

Press releases may be edited for formatting or style | March 16, 2018 Artificial Intelligence
PUNE, India, March 16, 2018 /PRNewswire/ -- ReportsnReports.com adds Artificial Intelligence in Healthcare Market is forecast to reach $7,988.8 million by 2022 from $667.1 million in 2016 at a CAGR of 52.68% during (2017-2022) driven by the growing usage of big data in healthcare industry, ability of AI to improve patient outcomes, imbalance between health workforce and patients, reducing the healthcare costs, growing importance on precision medicine, cross-industry partnerships, and significant increase in venture capital investments in AI in healthcare domain.

Browse 61 Market Data Tables and 71 Figures spread through 210 Pages and in-depth TOC on "Artificial Intelligence in Healthcare Market by Offering (Hardware, Software and Services), Technology (Deep Learning, Querying Method, NLP, and Context Aware Processing), Application, End-User Industry, and Geography - Global Forecast to 2022" http://www.reportsnreports.com/reports/985408-artificial-intelligence-in-healthcare-market-by-offering-hardware-software-and-services-technology-deep-learning-querying-method-nlp-and-context-aware-processing-application-end-user-industry-and-geograp-st-to-2022.html .

This report provides valuable insights into the ecosystem of the AI in healthcare market including the software companies, and chipset and medical solution providers. The major players in the AI in healthcare market are IBM Corporation (US), Intel Corporation (US), Google, Inc. (US), NVIDIA Corporation (US), Microsoft Corporation (US), iCarbonX (China), Next IT Corp. (US), CloudMedx Inc. (US), Carescore (US), Atomwise, Inc. (US), Zephyr Health, Inc. (US), Sentirian (US), BabyLabs, Inc. (US), Siemens Healthineers GmbH (Germany), Johnson & Johnson (US), Welltok, Inc. (US), General Vision, Inc. (US), Enlitic, Inc. (US), Recursion Pharmaceuticals (US), General Electric Company (US), Stryker Corporation (US), Deep Genomics, Inc. (Canada), Medtronic Plc. (Ireland), Koninklijke Philips N.V. (Netherlands), and Oncora Medical, Inc. (US).
stats
DOTmed text ad

NEW AROBELLA 1000D ADVANCED ULTRASOUND WOUND THERAPY FOR SALE OR RENT

Brand-New FDA-cleared Advanced Ultrasound Medical Device available for sale or lease to Wound Care Centers or any other Medical Facilities.The Arobella 1000D is designed for non-contact or debridement ultrasound wound healing therapy, or any other wounds

stats
Owing the factors of Natural Language Processing (NLP) to handle structured and unstructured data are driving the NLP market in AI in healthcare market. NLP currently holds the largest market share among the AI technologies. This demand has grown since the companies have started to structure the clinical data and find interpretation from them. Moreover the growing usage of internet and connected devices along with huge volume of patient's data driven the growth of this market.

Inquire for DISCOUNT on "Artificial Intelligence in Healthcare Market by Offering (Hardware, Software and Services), Technology (Deep Learning, Querying Method, NLP, and Context Aware Processing), Application, End-User Industry, and Geography - Global Forecast to 2022" research report at http://www.reportsnreports.com/contacts/discount.aspx?name=985408 .

You Must Be Logged In To Post A Comment